What drug enhances the output of respiratory tract fluid by reducing the adhesiveness and surface tension of the fluid which facilitates the removal of viscous mucus?

Choice A rationale

Reassuring the client without addressing the persistent cough would not be appropriate as it may signal a need for a different medication. The ACE inhibitor captopril can cause a bothersome, persistent cough in some patients due to increased bradykinin levels.

Choice B rationale

Instructing the patient to stop the medication immediately is not advised without consulting the healthcare provider. While the cough is a known side effect, stopping the medication abruptly may lead to unmanaged hypertension.

Choice C rationale

Scheduling an appointment with the provider to discuss changing to an angiotensin II receptor blocker (ARB) is appropriate. ARBs do not typically cause a persistent cough, making them a suitable alternative for patients who experience this side effect with ACE inhibitors.

Choice D rationale

Instructing the patient to go to the emergency room immediately is unnecessary as the persistent cough is a common side effect of ACE inhibitors and not an emergency situation. Emergency action is warranted for symptoms of angioedema, such as swelling of the face or throat.

Choice A rationale

Barrier contraceptives are recommended for women taking HMG-CoA reductase inhibitors due to the potential teratogenic effects of these drugs. This precaution is crucial as these medications can cause fetal harm if used during pregnancy.

Choice B rationale

While ophthalmic examinations may be important for other medications, they are not a primary concern for HMG-CoA reductase inhibitors. These drugs mainly affect cholesterol synthesis and have less direct impact on vision.

Choice C rationale

Although a cholesterol-lowering diet is beneficial, it is not the primary teaching point when discussing HMG-CoA reductase inhibitors. The emphasis should be on medication adherence and managing potential adverse effects.

Choice D rationale

Reporting respiratory symptoms is important for many medications but is not the primary focus for HMG-CoA reductase inhibitors. The priority is to inform patients about the importance of contraception and potential side effects related to the medication.